Truist Financial Corp Protara Therapeutics, Inc. Transaction History
Truist Financial Corp
- $65.3 Billion
- Q1 2024
A detailed history of Truist Financial Corp transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 20,000 shares of TARA stock, worth $40,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$40,599% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
40Shares Held
4.55MCall Options Held
102KPut Options Held
18.2K-
Opaleye Management Inc. Boston, MA2.69MShares$5.47 Million2.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA428KShares$868,0520.0% of portfolio
-
Boxer Capital, LLC San Diego, CA209KShares$424,7300.04% of portfolio
-
Ikarian Capital, LLC Dallas, TX203KShares$411,4830.11% of portfolio
-
Baker Bros. Advisors LP New York, NY200KShares$405,3320.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $22.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...